Cannabidiol Treatment for Neurological, Cognitive, and Psychiatric Symptoms in Sturge-Weber Syndrome

A prior drug trial of cannabidiol for treatment-resistant epilepsy in patients with Sturge-Weber syndrome (SWS), a rare neurovascular condition, implicated improvements in neurological, quality of life (QOL), neuropsychologic, psychiatric, and motor outcomes.

Source: Pediatric Neurology - November 11, 2022 Category: Neurology Authors: Lindsay F. Smegal, Pooja Vedmurthy, Matthew Ryan, Melissa Eagen, Nicole Whiston Andrejow, Kristie Sweeney, Teressa Garcia Reidy, SangEun Yeom, Doris D. Lin, Stacy J. Suskauer, Luther G. Kalb, Jay A. Salpekar, T. Andrew Zabel, Anne M. Comi Tags: Research Paper Source Type: research